Among AD aMCI participants, 15 (24%) were taking antidepressants (SSRI) and 23 (21%) were taking cognitive-enhancing medication (cholinesterase inhibitors: n = 22; memantine: n = 1; their combination: n = 1). Here, BCHE is linked to Alzheimer disease.